Maintenance Notice (3:15 - 7:30 AM February 22, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Notice of Discontinuing the Use of Password-Protected Compressed Files | Product Document Searching Made Easy by 2D Code! | TCI Life Science News February 2025 | [Product Highlights] Chemiluminescent Reagents for... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
Tyrosine Kinase Inhibitor: Tyrphostin AG1478
No.173(April 2017)

Tyrphostin AG1478 (1) is an inhibitor of protein tyrosine kinase and is highly selective for epidermal growth factor receptor (EGFR).1) 1 can inhibit EGFR with IC50 of 3 nM, while the IC50s for other kinases are higher as shown in the Table.1) It was reported that the combination of 1 with cytostatic drugs, Cisplatin or Paclitaxel, induces a synergistic effect of growth inhibition of endometrial cancer cells.2)

References
- 1)Tyrosine kinase inhibition: An approach to drug development
- 2)Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells
Related Compounds
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.